Advertisement

Topics

Hovione SA Company Profile

16:12 EDT 26th September 2017 | BioPortfolio

Corporate descriptionHovione is an international group dedicated to the synthesis of APIs and serving exclusively the Pharma industry. With FDA inspected plants in Europe and the Far East and sales offices in Hong Kong, Switzerland and New Jersey, Hovione is committed to the highest levels of service and quality. Hovione’s capabilities include process chemistry, worldwide regulatory affairs, kilo to multi-ton manufacture of complex multi-step chemistry of APIs under FDA and ICH cGMP standards.

Within the scope of custom synthesis, Hovione takes full responsibility for all matters relating to the API from pre-IND to NDA and beyond, ensuring fast and successful product launches. In the past 5 years Hovione was the API manufacturer behind 4 successful product launches in the USA.



Markets served

Hovione serves Small and Large Pharma Companies worldwide, exporting 55% of its products and services to the USA, 25% to Europe and 15% to Japan.



Technical services

Hovione offers all technical services within the scope of the API on a confidential basis and with total transparency & online communication to its customer. Lab development, pilot-scale GMP production, process industrialization, validation and regulatory filings assure a complete one-stop-shop range of services.



Major products

Hovione offers custom synthesis of APIs and regulated intermediates for oral, topical, inhalation and injectable grades, including sterile bulk, having produced industrially more than 30 different APIs. Hovione is a major source of semi-synthetic tetracyclines and corticosteroids, and is the largest independent supplier of contrast agents.

Location

Sete Casas
Loures
2674-506
Portugal

Contact

Phone: +351 21 9829200
Fax: +351 21 9829388
Email: jpires@hovione.com


News Articles [9 Associated News Articles listed on BioPortfolio]

Hovione launches first clinical trial, more to come

Hovione has launched of its first clinical trial and has already set sights on a second as the CDMO hopes to establish licensing partnership with pharma, says VP.

Hovione Announces Start of Phase 1 Clinical Trial of HY02, a Proprietary Minocycline Sterile Ointment to Treat a Subset of Anterior Ocular Inflammation

CORK, Ireland, May 25, 2017 /PRNewswire/ -- Hovione today announced the launch of its first clinical trial. Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a proprie...

Hovione Announces Start Of Phase l Clinical Trial Of HY02, A Proprietary Minocycline Sterile Ointment To Treat A Subset Of Anterior Ocular Inflammation

  Life Sciences Jobs   ...

Hovione Starts Phase 1 Clinical Trial of HY02

HY02 is a proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation

Clinical trial launched for eye ointment offering topical delivery of antibiotic

Hovione has announced the launch of its Phase I clinical trial of its minocycline sterile ointment, HY02, for the treatment of a subset of ocular surface inflammation.

Hovione FarmaCiencia SA Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10052017] Prices from USD $250

SummaryHovione FarmaCiencia SA Hovione is a pharmaceutical company that develops and manufactures active pharmaceutical ingredients APIs and drug product intermediates. It offers offpatent API product...

Hovione FarmaCiencia SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryHovione FarmaCiencia SA Hovione is a pharmaceutical company that develops and manufactures active pharmaceutical ingredients APIs and drug product intermediates. It offers offpatent API product...

Global Dry Powder Inhaler Device Market Research 2011 2022 [Report Updated: 12042017] Prices from USD $1520

SummaryThe global Dry Powder Inhaler Device market is estimated to reach 645 Million USD in 2017. The objective of report is to define, segment, and project the market on the basis of type, applicatio...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Hovione SA

Corporate descriptionHovione is an international group dedicated to the synthesis of APIs and serving exclusively the Pharma industry. With FDA inspected plants in Europe and the Far East and sales o...

Hovione

A Hovione foi fundada em 1959 por Ivan Villax, investigador químico, empenhado no desenvolvimento de tetraciclinas e corticoesteroídes anti-inflamatórios. O sucesso da investigação, financiada pe...

Hovione FarmaCiencia SA

More Information about "Hovione SA" on BioPortfolio

We have published hundreds of Hovione SA news stories on BioPortfolio along with dozens of Hovione SA Clinical Trials and PubMed Articles about Hovione SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hovione SA Companies in our database. You can also find out about relevant Hovione SA Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record